Opening book details…
Can I read Cured II à LENT Cancer Survivorship Research and Education: Late Effects on Normal Tissues on EtoBox?
Cured II à LENT Cancer Survivorship Research and Education: Late Effects on Normal Tissues by Lois B. Travis MD, ScD (auth.), Philip Rubin MD, Louis S. Constine MD, Lawrence B. Marks MD, Paul Okunieff MD (eds.) is a nonfiction available to read on EtoBox.
What is Cured II à LENT Cancer Survivorship Research and Education: Late Effects on Normal Tissues about?
Multimodal treatment lies at the heart of the improvement in cancer cure rates. However, the more aggressive the treatment delivery in terms of dose, time and volume for radiation and chemotherapy, the more adverse effects in normal tissues can be anticipated. Against this background, a major paradigm shift has taken place in that there is a new focus on cancer survivorship. Put another way, there has been a realization that prolongation of life must be accompanied by maintenance of the quality of life: the life worth saving must be worth living. Common Toxicity Criteria (CTC) have been applied to assess the quality of survival of long-term cancer survivors. In the 1950s, the concept of late effects was considered unique to radiation. Yet, when the CTC were first developed more than two decades ago, they applied to acute adverse events due to chemotherapy (v1.0). Since late changes due to drugs were not recognized until years later, the initial update (v2.0) additionally incorporated only acute radiation toxicity. More recently, however, v3.0 has been designed to apply to all modalities and to encompass both early and late treatment effects. Other important developments in the Unit
Who reads Cured II à LENT Cancer Survivorship Research and Education: Late Effects on Normal Tissues?
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Lois B. Travis MD, ScD (auth.), Philip Rubin MD, Louis S. Constine MD, Lawrence B. Marks MD, Paul Okunieff MD (eds.)
- Publisher
- Springer-Verlag Berlin Heidelberg
- Published
- 2008
- Language
- EN
- ISBN
- 9783540762713
- Category
- nonfiction
- Subjects
- Medical, Medicine
Other editions & translations
More by Lois B. Travis MD, ScD (auth.), Philip Rubin MD, Louis S. Constine MD, Lawrence B. Marks MD, Paul Okunieff MD (eds.)
Similar books
- CURED I - LENT Late Effects of Cancer Treatment on Normal Tissues (Medical Radiology) — Philip Rubin, L.S. Constine, Lawrence B. Marks, Paul Okunieff (2007)
- ALERT - Adverse Late Effects of Cancer Treatment: Volume 1: General Concepts and Specific Precepts (Medical Radiology) — Craig C. Earle, Lois B. Travis (auth.), Philip Rubin, Louis S. Constine, Lawrence B. Marks (2014)
- Adjuvant Therapies And Markers Of Post-surgical Minimal Residual Disease Ii: Adjuvant Therapies Of The Various Primary Tumors (recent Results In Cancer Research) — J. Lemerle, M. F. Tournade, C. Patte (auth.), Professor Gianni Bonadonna, Professor Georges Mathé, Professor Sydney E. Salmon (1979)
- Supportive Care in Cancer Patients II (Recent Results in Cancer Research, 121) — B. Roos (auth.), Professor Dr. Hans-Jörg Senn, Oberschweser Agnes Glaus (1991)
- Clinically Relevant Resistance In Cancer Chemotherapy (cancer Treatment And Research) — Alison J. Davis, Ian F. Tannock (auth.), Borje Andersson M.D., Ph.D, David Murray (2002)
- ALERT • Adverse Late Effects of Cancer Treatment: Volume 2: Normal Tissue Specific Sites and Systems (Medical Radiology) — Susannah Yovino, Young Kwok (auth.), Philip Rubin, Louis S. Constine, Lawrence B. Marks (2014)